Semaglutide is typically administered once weekly for the treatment of type 2 diabetes or once weekly for chronic weight management
The SUSTAIN and SELECT trials demonstrated that GLP-1 treatment independently lowers cardiovascular events, meaning patients on both aspirin and semaglutide benefit from dual cardioprotection
Some people respond better to semaglutide-based drugs, while others may achieve greater success with tirzepatide-based treatments
W modelu przewlekego nieprzewidywalnego stresu dziaanie standardowych lekw przeciwdepresyjnych byo osabione przez cisze warunki eksperymentu
Lofton has served on advisory boards or received research funding and speaking fees from Novo Nordisk, Eli Lilly, and Currax

You should contact your GP if you experience : Unexplained weight gain , particularly affecting the face (moon face), neck (buffalo hump), and abdomen, with relatively thin arms and legs Persistent hypertension that is difficult to control with standard medications Easy bruising or thin, fragile skin that heals poorly Purple or red stretch marks (striae) on the abdomen, thighs, or breasts Muscle weakness , particularly affecting the shoulders and hips Mood changes including depression, anxiety, or irritability that persist despite usual management Irregular menstrual periods or reduced libido Recurrent infections or poor wound healing New-onset diabetes or worsening glycaemic control in established diabetes Seek urgent medical attention if you develop signs of adrenal crisis, which can occur in patients with adrenal insufficiency (often after withdrawal of long-term steroids)